Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 2
1949 1
1951 1
1953 1
1956 1
1958 1
1959 1
1961 1
1964 2
1965 14
1966 42
1967 57
1968 96
1969 79
1970 103
1971 80
1972 91
1973 108
1974 134
1975 83
1976 87
1977 106
1978 90
1979 95
1980 100
1981 95
1982 122
1983 96
1984 123
1985 125
1986 142
1987 155
1988 158
1989 214
1990 251
1991 292
1992 260
1993 346
1994 304
1995 279
1996 284
1997 244
1998 218
1999 202
2000 209
2001 193
2002 207
2003 199
2004 208
2005 226
2006 245
2007 224
2008 265
2009 273
2010 290
2011 303
2012 313
2013 319
2014 363
2015 332
2016 338
2017 346
2018 360
2019 356
2020 374
2021 337
2022 363
2023 258
2024 81

Text availability

Article attribute

Article type

Publication date

Search Results

11,498 results

Results by year

Filters applied: . Clear all
Page 1
How to prevent allopurinol hypersensitivity reactions?
Stamp LK, Barclay ML. Stamp LK, et al. Rheumatology (Oxford). 2018 Jan 1;57(suppl_1):i35-i41. doi: 10.1093/rheumatology/kex422. Rheumatology (Oxford). 2018. PMID: 29272508 Review.
Allopurinol hypersensitivity syndrome (AHS) is a severe and sometimes life-threatening adverse drug reaction. ...A low starting allopurinol dose may reduce AHS risk, but the relationship between maintenance dose and AHS is more controversial. ...
Allopurinol hypersensitivity syndrome (AHS) is a severe and sometimes life-threatening adverse drug reaction. ...A low starting al
Mechanisms and rationale for uricase use in patients with gout.
Schlesinger N, Pérez-Ruiz F, Lioté F. Schlesinger N, et al. Nat Rev Rheumatol. 2023 Oct;19(10):640-649. doi: 10.1038/s41584-023-01006-3. Epub 2023 Sep 8. Nat Rev Rheumatol. 2023. PMID: 37684360 Review.
Xanthine oxidase inhibitors such as allopurinol and febuxostat have been the mainstay urate-lowering therapy (ULT) for treating hyperuricaemia in patients with gout. ...
Xanthine oxidase inhibitors such as allopurinol and febuxostat have been the mainstay urate-lowering therapy (ULT) for treating hyper …
Allopurinol-induced DRESS syndrome.
Markel A. Markel A. Isr Med Assoc J. 2005 Oct;7(10):656-60. Isr Med Assoc J. 2005. PMID: 16259349 Free article. Review.
Complications, including renal calculi, uric acid nephropathy and gout, occur in a small proportion of patients. Allopurinol, an analog of hypoxanthine, has been widely used in clinical practice for over 30 years for the treatment of hyperuricemia and gout. ...A syndrome c …
Complications, including renal calculi, uric acid nephropathy and gout, occur in a small proportion of patients. Allopurinol, an anal …
Allopurinol.
Greene MI, Fujimoto WY, Seegmiller JE. Greene MI, et al. N Engl J Med. 1969 Apr 24;280(17):961. N Engl J Med. 1969. PMID: 5775640 No abstract available.
Allopurinol kinetics.
Hande K, Reed E, Chabner B. Hande K, et al. Clin Pharmacol Ther. 1978 May;23(5):598-605. doi: 10.1002/cpt1978235598. Clin Pharmacol Ther. 1978. PMID: 639435
With this assay, serum disappearance characteristics of intravenous and orally administered allopurinol have been investigated in man. Serum concentrations of both allopurinol and oxipurinol reach levels above 1 X 10(-5) M within minutes of intravenous administratio …
With this assay, serum disappearance characteristics of intravenous and orally administered allopurinol have been investigated in man …
Allopurinol for chronic prostatitis.
McNaughton Collins M, Wilt T. McNaughton Collins M, et al. Cochrane Database Syst Rev. 2000;(2):CD001041. doi: 10.1002/14651858.CD001041. Cochrane Database Syst Rev. 2000. PMID: 10796738 Updated. Review.
SELECTION CRITERIA: All randomized trials of allopurinol versus placebo used to treat patients with chronic prostatitis. ...Between days 45-225, the mean score was -0.95 (s.d. 0.19) for the allopurinol group (7 men), compared with -0.47 (s.d. 0.21) for the placebo g …
SELECTION CRITERIA: All randomized trials of allopurinol versus placebo used to treat patients with chronic prostatitis. ...Between d …
Bullous cutaneous reactions.
Jira M, Amezyane T. Jira M, et al. Pan Afr Med J. 2018 Nov 16;31:188. doi: 10.11604/pamj.2018.31.188.16608. eCollection 2018. Pan Afr Med J. 2018. PMID: 31065326 Free PMC article. No abstract available.
Semi-mechanistic Modeling of Hypoxanthine, Xanthine, and Uric Acid Metabolism in Asphyxiated Neonates.
Chu WY, Allegaert K, Dorlo TPC, Huitema ADR; ALBINO Study Group. Chu WY, et al. Clin Pharmacokinet. 2022 Nov;61(11):1545-1558. doi: 10.1007/s40262-022-01164-9. Epub 2022 Aug 30. Clin Pharmacokinet. 2022. PMID: 36040612 Free PMC article.
Model development was accomplished by nonlinear mixed-effects modeling (NONMEM(), version 7.5). RESULTS: In total, 20 neonates treated with allopurinol and 17 neonates treated with mannitol were included in this analysis. ...Half-maximal xanthine oxidoreductase inhibition …
Model development was accomplished by nonlinear mixed-effects modeling (NONMEM(), version 7.5). RESULTS: In total, 20 neonates treated with …
Allopurinol toxicity.
Sergent JS. Sergent JS. South Med J. 1979 Nov;72(11):1359-60. doi: 10.1097/00007611-197911000-00003. South Med J. 1979. PMID: 505064 No abstract available.
11,498 results
You have reached the last available page of results. Please see the User Guide for more information.